nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—CYP1A2—type 2 diabetes mellitus	0.336	1	CbGaD
Niclosamide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0465	0.0986	CbGbCtD
Niclosamide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0425	0.0902	CbGbCtD
Niclosamide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0395	0.0839	CbGbCtD
Niclosamide—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0344	0.073	CbGbCtD
Niclosamide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0336	0.0713	CbGbCtD
Niclosamide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0336	0.0713	CbGbCtD
Niclosamide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.031	0.0658	CbGbCtD
Niclosamide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0299	0.0635	CbGbCtD
Niclosamide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0274	0.0581	CbGbCtD
Niclosamide—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0271	0.0575	CbGbCtD
Niclosamide—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0256	0.0544	CbGbCtD
Niclosamide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0255	0.054	CbGbCtD
Niclosamide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0244	0.0518	CbGbCtD
Niclosamide—STAT3—brown adipose tissue—type 2 diabetes mellitus	0.0197	0.352	CbGeAlD
Niclosamide—CYP1A2—Losartan—type 2 diabetes mellitus	0.0175	0.037	CbGbCtD
Niclosamide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0172	0.0365	CbGbCtD
Niclosamide—CYP2C9—Losartan—type 2 diabetes mellitus	0.0157	0.0334	CbGbCtD
Niclosamide—STAT3—endothelium—type 2 diabetes mellitus	0.00731	0.131	CbGeAlD
Niclosamide—STAT3—islet of Langerhans—type 2 diabetes mellitus	0.00416	0.0745	CbGeAlD
Niclosamide—STAT3—retina—type 2 diabetes mellitus	0.00356	0.0637	CbGeAlD
Niclosamide—STAT3—nephron tubule—type 2 diabetes mellitus	0.00335	0.06	CbGeAlD
Niclosamide—STAT3—cardiovascular system—type 2 diabetes mellitus	0.00301	0.0539	CbGeAlD
Niclosamide—STAT3—kidney—type 2 diabetes mellitus	0.00294	0.0527	CbGeAlD
Niclosamide—STAT3—pancreas—type 2 diabetes mellitus	0.00292	0.0524	CbGeAlD
Niclosamide—STAT3—cortex of kidney—type 2 diabetes mellitus	0.00287	0.0514	CbGeAlD
Niclosamide—STAT3—adipose tissue—type 2 diabetes mellitus	0.00265	0.0475	CbGeAlD
Niclosamide—STAT3—liver—type 2 diabetes mellitus	0.00186	0.0333	CbGeAlD
Niclosamide—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000675	0.0121	CbGeAlD
Niclosamide—CYP1A2—liver—type 2 diabetes mellitus	0.00044	0.00788	CbGeAlD
Niclosamide—CYP2C9—liver—type 2 diabetes mellitus	0.000417	0.00748	CbGeAlD
Niclosamide—Diflunisal—PTGS2—type 2 diabetes mellitus	0.000343	0.217	CrCbGaD
Niclosamide—Meclofenamic acid—PTGS2—type 2 diabetes mellitus	0.000305	0.193	CrCbGaD
Niclosamide—Diflunisal—ALB—type 2 diabetes mellitus	0.000305	0.193	CrCbGaD
Niclosamide—Clonazepam—CYP2E1—type 2 diabetes mellitus	0.000289	0.182	CrCbGaD
Niclosamide—Clonazepam—CYP3A4—type 2 diabetes mellitus	0.000182	0.115	CrCbGaD
Niclosamide—Clonazepam—ALB—type 2 diabetes mellitus	0.000159	0.1	CrCbGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	1.96e-05	0.000144	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	1.96e-05	0.000144	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—BHMT—type 2 diabetes mellitus	1.92e-05	0.000141	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—IL6—type 2 diabetes mellitus	1.91e-05	0.000141	CbGpPWpGaD
Niclosamide—STAT3—Disease—SERPINE1—type 2 diabetes mellitus	1.91e-05	0.000141	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.91e-05	0.000141	CbGpPWpGaD
Niclosamide—STAT3—Immune System—BCL2—type 2 diabetes mellitus	1.9e-05	0.00014	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.87e-05	0.000138	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.87e-05	0.000137	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GPD2—type 2 diabetes mellitus	1.86e-05	0.000137	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CDO1—type 2 diabetes mellitus	1.86e-05	0.000137	CbGpPWpGaD
Niclosamide—STAT3—Immune System—RELA—type 2 diabetes mellitus	1.86e-05	0.000137	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—C3—type 2 diabetes mellitus	1.83e-05	0.000135	CbGpPWpGaD
Niclosamide—STAT3—Disease—PIK3R1—type 2 diabetes mellitus	1.82e-05	0.000134	CbGpPWpGaD
Niclosamide—STAT3—Disease—NOS3—type 2 diabetes mellitus	1.82e-05	0.000134	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.82e-05	0.000134	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.81e-05	0.000133	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	1.78e-05	0.000131	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—AKT1—type 2 diabetes mellitus	1.77e-05	0.00013	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.76e-05	0.000129	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.75e-05	0.000129	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.74e-05	0.000128	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AGT—type 2 diabetes mellitus	1.74e-05	0.000128	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.71e-05	0.000126	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—LEP—type 2 diabetes mellitus	1.71e-05	0.000126	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—APOE—type 2 diabetes mellitus	1.71e-05	0.000126	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.69e-05	0.000124	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AANAT—type 2 diabetes mellitus	1.68e-05	0.000124	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PTGDS—type 2 diabetes mellitus	1.68e-05	0.000124	CbGpPWpGaD
Niclosamide—STAT3—Disease—PTGS2—type 2 diabetes mellitus	1.67e-05	0.000123	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	1.64e-05	0.000121	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	1.64e-05	0.000121	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.63e-05	0.00012	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.61e-05	0.000118	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.6e-05	0.000118	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.6e-05	0.000117	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	1.59e-05	0.000117	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	1.59e-05	0.000117	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.59e-05	0.000117	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	1.58e-05	0.000117	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	1.58e-05	0.000117	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	1.58e-05	0.000117	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.58e-05	0.000117	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	1.58e-05	0.000117	CbGpPWpGaD
Niclosamide—STAT3—Immune System—NFKB1—type 2 diabetes mellitus	1.57e-05	0.000115	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.55e-05	0.000114	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.54e-05	0.000114	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	1.53e-05	0.000113	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.52e-05	0.000112	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	1.52e-05	0.000112	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1.5e-05	0.00011	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	1.48e-05	0.000109	CbGpPWpGaD
Niclosamide—STAT3—Immune System—SRC—type 2 diabetes mellitus	1.46e-05	0.000108	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—INS—type 2 diabetes mellitus	1.46e-05	0.000107	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	1.45e-05	0.000107	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	1.45e-05	0.000107	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.43e-05	0.000106	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	1.41e-05	0.000104	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.41e-05	0.000104	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.41e-05	0.000104	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	1.4e-05	0.000103	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	1.4e-05	0.000103	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	1.39e-05	0.000103	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	1.37e-05	0.000101	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	1.36e-05	9.99e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.35e-05	9.96e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	1.35e-05	9.96e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	1.35e-05	9.96e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	1.35e-05	9.96e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	1.35e-05	9.96e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—SRC—type 2 diabetes mellitus	1.35e-05	9.94e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	1.35e-05	9.91e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	1.35e-05	9.91e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	1.35e-05	9.91e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.34e-05	9.85e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	1.31e-05	9.64e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	1.29e-05	9.5e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	1.29e-05	9.5e-05	CbGpPWpGaD
Niclosamide—STAT3—Immune System—EGFR—type 2 diabetes mellitus	1.28e-05	9.43e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.28e-05	9.41e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.28e-05	9.41e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	1.24e-05	9.14e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	1.24e-05	9.14e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	1.24e-05	9.11e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	1.24e-05	9.11e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	1.22e-05	8.98e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.22e-05	8.98e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—TGFB1—type 2 diabetes mellitus	1.21e-05	8.88e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	1.21e-05	8.87e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.2e-05	8.85e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	1.2e-05	8.83e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	1.2e-05	8.83e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	1.2e-05	8.83e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—EGFR—type 2 diabetes mellitus	1.18e-05	8.71e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.16e-05	8.56e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	1.15e-05	8.47e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	1.15e-05	8.47e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	1.15e-05	8.47e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.13e-05	8.3e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.11e-05	8.17e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	1.1e-05	8.12e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	1.1e-05	8.12e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.08e-05	7.99e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.08e-05	7.97e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.06e-05	7.81e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.06e-05	7.81e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.06e-05	7.77e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.05e-05	7.77e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.04e-05	7.68e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.04e-05	7.67e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.03e-05	7.55e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	1.02e-05	7.55e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	1.02e-05	7.55e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.02e-05	7.55e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.02e-05	7.51e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.02e-05	7.51e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.02e-05	7.51e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.02e-05	7.51e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.01e-05	7.47e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	9.94e-06	7.31e-05	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL6—type 2 diabetes mellitus	9.85e-06	7.25e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.81e-06	7.22e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	9.78e-06	7.2e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	9.64e-06	7.09e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	9.5e-06	6.99e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	9.49e-06	6.98e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SRC—type 2 diabetes mellitus	9.45e-06	6.96e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	9.31e-06	6.85e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	9.26e-06	6.81e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.21e-06	6.78e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	9.2e-06	6.77e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—IL6—type 2 diabetes mellitus	9.09e-06	6.69e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	9.09e-06	6.69e-05	CbGpPWpGaD
Niclosamide—STAT3—Immune System—AKT1—type 2 diabetes mellitus	9.08e-06	6.69e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	9.02e-06	6.64e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	9.01e-06	6.64e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	8.72e-06	6.42e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	8.72e-06	6.42e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	8.72e-06	6.42e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	8.72e-06	6.42e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	8.49e-06	6.25e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.45e-06	6.22e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—AKT1—type 2 diabetes mellitus	8.39e-06	6.17e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.38e-06	6.17e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	8.36e-06	6.15e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	8.31e-06	6.12e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	8.31e-06	6.12e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.28e-06	6.1e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	8.15e-06	6e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.12e-06	5.97e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	8.11e-06	5.97e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	8.1e-06	5.96e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	8.1e-06	5.96e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	8.1e-06	5.96e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	8.05e-06	5.93e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.95e-06	5.85e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	7.91e-06	5.82e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.86e-06	5.79e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	7.82e-06	5.75e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	7.77e-06	5.72e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.29e-06	5.37e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	7.27e-06	5.35e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	7.27e-06	5.35e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	7.27e-06	5.35e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	7.25e-06	5.34e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	7.13e-06	5.25e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	7.1e-06	5.23e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	7.1e-06	5.23e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	7.07e-06	5.2e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.97e-06	5.13e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	6.97e-06	5.13e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.93e-06	5.1e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	6.92e-06	5.1e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	6.92e-06	5.1e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	6.92e-06	5.1e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	6.92e-06	5.09e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	6.88e-06	5.07e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	6.76e-06	4.97e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	6.68e-06	4.92e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	6.65e-06	4.89e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	6.57e-06	4.84e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	6.57e-06	4.84e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	6.41e-06	4.72e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.38e-06	4.69e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL6—type 2 diabetes mellitus	6.37e-06	4.69e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	6.3e-06	4.64e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	6.3e-06	4.64e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.23e-06	4.58e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	6.21e-06	4.57e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	6.21e-06	4.57e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	6.21e-06	4.57e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	6.1e-06	4.49e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	6.04e-06	4.45e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.96e-06	4.39e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	5.91e-06	4.35e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.87e-06	4.32e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	5.68e-06	4.18e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	5.62e-06	4.13e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	5.48e-06	4.03e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.45e-06	4.01e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.43e-06	4e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	5.43e-06	4e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	5.41e-06	3.98e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	5.38e-06	3.96e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	5.38e-06	3.96e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	5.33e-06	3.93e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	5.18e-06	3.81e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	5.04e-06	3.71e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.94e-06	3.64e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4.84e-06	3.56e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	4.82e-06	3.55e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	4.7e-06	3.46e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	4.64e-06	3.42e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.64e-06	3.42e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	4.64e-06	3.41e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	4.62e-06	3.4e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	4.56e-06	3.36e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	4.45e-06	3.28e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	4.42e-06	3.26e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	4.37e-06	3.22e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.3e-06	3.17e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	4.23e-06	3.11e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.22e-06	3.11e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	4.16e-06	3.06e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	4.14e-06	3.05e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.14e-06	3.04e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.12e-06	3.03e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	4.1e-06	3.02e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.01e-06	2.96e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.96e-06	2.92e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.8e-06	2.8e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.73e-06	2.75e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.61e-06	2.66e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.61e-06	2.66e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.55e-06	2.62e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	3.54e-06	2.61e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.54e-06	2.61e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.5e-06	2.58e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	3.25e-06	2.39e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	3.1e-06	2.29e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	3.1e-06	2.29e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.08e-06	2.27e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.03e-06	2.23e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.84e-06	2.09e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.77e-06	2.04e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.65e-06	1.95e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.65e-06	1.95e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.43e-06	1.79e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.43e-06	1.05e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.22e-06	8.98e-06	CbGpPWpGaD
